Register Now
Log In
中文/English
About ITMCTR|Search Trials|About Us|News
Influence of Peanut Consumption on Cardiovascular Risk Factors and the Gut Microbiome: A Randomized Clinical Trial

注册号：

Registration number：

ITMCTR2024000050

最近更新日期：

Date of Last Refreshed on：

2024-04-24

注册时间：

Date of Registration：

2024-04-24

注册号状态：

Registration Status：

补注册

Retrospective registration

注册题目：

Public title：

Influence of Peanut Consumption on Cardiovascular Risk Factors and the Gut Microbiome: A Randomized Clinical Trial

注册题目简写：

English Acronym：

研究课题的正式科学名称：

Scientific title：

Influence of Peanut Consumption on Cardiovascular Risk Factors and the Gut Microbiome: A Randomized Clinical Trial

研究课题的正式科学名称简写：

Scientific title acronym：

研究课题代号(代码)：

Study subject ID：

在二级注册机构或其它机构的注册号：

The registration number of the Partner Registry or other register：

申请注册联系人：

研究负责人：

Applicant：

Thi Du Chi TRAN

Study leader：

Xiao-Ou SHU

申请注册联系人电话：

Applicant telephone：

+84 947611475

研究负责人电话：

Study leader's telephone：

615-936-0713

申请注册联系人传真 ：

Applicant Fax：

研究负责人传真：

Study leader's fax：

申请注册联系人电子邮件：

Applicant E-mail：

v.chittd@vinmec.com

研究负责人电子邮件：

Study leader's E-mail：

xiao-ou.shu@vumc.org

申请单位网址(自愿提供)：

Study leader's website(voluntary supply)：

研究负责人网址(自愿提供)：

Study leader's website
(voluntary supply)：

申请注册联系人通讯地址：

研究负责人通讯地址：

Applicant address：

Vinmec International General Hospital JSC, 458 Minh Khai street, Vinh Tuy ward, Hai Ba Trung district, Hanoi, Vietnam

Study leader's address：

Vanderbilt University School of Medicine, 1211 Medical Center Drive, Nashville, TN 37232, USA

申请注册联系人邮政编码：

Applicant postcode：

研究负责人邮政编码：

Study leader's postcode：

申请人所在单位：

Applicant's institution：

Vinmec International General Hospital JSC

是否获伦理委员会批准：

Approved by ethic committee：

伦理委员会批件文号：

Approved No. of ethic committee：

319/2018/QD-VMEC

伦理委员会批件附件：

Approved file of Ethical Committee：

View

批准本研究的伦理委员会名称：

Name of the ethic committee：

Institutional Ethical Review Board for Biomedical Research - Vinmec International General Hospital JSC

伦理委员会批准日期：

Date of approved by ethic committee：

2018/9/20 0:00:00

伦理委员会联系人：

Contact Name of the ethic committee：

Quynh Hoa PHAM

伦理委员会联系地址：

Contact Address of the ethic committee：

Institutional Ethical Review Board for Biomedical Research - Vinmec International General Hospital JSC, 458 Minh Khai street, Vinh Tuy ward, Hai Ba Trung district, Hanoi, Vietnam

伦理委员会联系人电话：

Contact phone of the ethic committee：

+84 2439750028-6236

伦理委员会联系人邮箱：

Contact email of the ethic committee：

v.hoapq@vinmec.com

研究实施负责（组长）单位：

Primary sponsor：

Division of Epidemiology, Vanderebilt University School of Medicine

研究实施负责（组长）单位地址：

Primary sponsor's address：

Vanderbilt University School of Medicine, 1211 Medical Center Drive, Nashville, TN 37232, USA

试验主办单位(项目批准或申办者)：

Secondary sponsor：

国家：

省(直辖市)：

市(区县)：

Country：

Vietnam

Province：

Hanoi

City：

Hanoi

单位(医院)：

具体地址：

Institution
hospital：

Vinmec International General Hospital JSC

Address：

458 Minh Khai street, Vinh Tuy ward, Hai Ba Trung district, Hanoi, Vietnam

经费或物资来源：

Source(s) of funding：

US Peanut Institute

研究疾病：

研究疾病代码：

Target disease：

Cardiovascular risk biomarkers and gut microbiome

Target disease code：

研究类型：

Study type：

干预性研究

Interventional study

研究设计：

Study design：

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段：

Study phase：

其它

Others

研究目的：

Objectives of Study：

The objectives of the study are to conduct a randomized clinical trial among a population at high risk for CVD, to evaluate the influence of short-term peanut supplementation on CVD risk factors and the gut microbiome, and to investigate whether peanut consumption may alter gut microbiota to lower the risk of CVD. By means of this study, we anticipate obtaining strong and direct scientific evidence regarding the effect of peanut consumption on cardiovascular health while gaining an in-depth understanding of the underlying biological mechanisms for the protective association between peanut intake and CVD risk.

药物成份或治疗方案详述：

Description for medicine or protocol of treatment in detail：

纳入标准：

Inclusion criteria

100 participants (50 each arm) 1. Age: 40 – 70, FOBT negative 2. Do not consume peanut or other tree nuts/seeds more than 1 time per week. 3. Self-reported diabetes/prediabetes but not on diabetes medication 4. Or self-reported dyslipidemia but not on lipid or triglyceride lowing medication 5. Or BMI>=25 or waist circumference >90 cm for man or >80 cm for women 6. Or systolic/diastolic blood pressure ≥ 130/85 mmHg

排除标准：

Exclusion criteria：

Individuals meet any of the following conditions are not eligible for the study 1. Known and suspected peanut/peanut containing products allergy 2. Kidney disease 3. Liver disease 4. Cardiovascular disease 5. Myocardial infarction 6. Cancer 7. Stroke 8. Drink more than 2 units of alcohol (2 cups of wine, 2 shuts of liquid or 2 cans of beer) weekly 9. On diabetes medications currently or during past 3 months 10. On lipid or triglyceride lowing medications currently or during past 3 months 11. Hospitalized in the past three months 12. Received chemotherapy, immune suppressive treatment, antibiotics during last 3 months 13. Have gained or lost more than 2.5 kg of weight in the last 3 months

研究实施时间：

Study execute time：

从From 2019-04-10

至To      2020-10-01

征募观察对象时间：

Recruiting time：

从From 2019-04-18

至To      2020-06-01

干预措施：

Interventions：

组别：

样本量：

49

Group：

Arm B (Control)

Sample size：

干预措施：

干预措施代码：

Intervention：

No intervention. The controls follow their usual dietary habits for 16 weeks

Intervention code：

组别：

样本量：

51

Group：

Arm A (Peanut Intervention)

Sample size：

干预措施：

干预措施代码：

Intervention：

consume 50 gram plain peanuts (unsalted and unsweetened) daily for 16 weeks

Intervention code：

样本总量 Total sample size ： 100

研究实施地点：

Countries of recruitment
and research settings：

国家：

省(直辖市)：

市(区县)：

Country：

Vietnam

Province：

Hanoi

City：

Hanoi

单位(医院)：

单位级别：

Institution/hospital：

Vinmec International General Hospital Joint Stock Company

Level of the institution：

unclassified

测量指标：

Outcomes：

指标中文名：

指标类型：

主要指标

Outcome：

Plasma insulin

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

指标中文名：

指标类型：

主要指标

Outcome：

Glucose

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

指标中文名：

指标类型：

主要指标

Outcome：

Urinary metabolites

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

指标中文名：

指标类型：

主要指标

Outcome：

Plasma CRP

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

指标中文名：

指标类型：

主要指标

Outcome：

Lipid profile

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

指标中文名：

指标类型：

主要指标

Outcome：

Gut microbiome profile

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

指标中文名：

指标类型：

主要指标

Outcome：

HbA1C

Type：

Primary indicator

测量时间点：

测量方法：

Measure time point of outcome：

Measure method：

采集人体标本：

Collecting sample(s)
from participants：

标本中文名：

组织：

Sample Name：

Urine

Tissue：

人体标本去向

使用后保存

说明

Fate of sample 

Preservation after use

Note：

标本中文名：

组织：

Sample Name：

Blood

Tissue：

人体标本去向

使用后保存

说明

Fate of sample 

Preservation after use

Note：

标本中文名：

组织：

Sample Name：

Stool

Tissue：

人体标本去向

使用后保存

说明

Fate of sample 

Preservation after use

Note：

征募研究对象情况：

结束

Completed

年龄范围：

最小 40 岁
Min age years
最大 70 岁
Max age years

Recruiting status：

Participant age：

性别：

Gender：

男女均可

Both

随机方法（请说明由何人用什么方法产生随机序列）：

Randomization Procedure (please state who generates the random number sequence and by what method)：

100 enrolled study participants was randomized on rolling basis. Once a study participant signed a written informed consent and was determined to be eligible for enrollment, the field operation director allocate him/her into either intervention group or control group using a stratified permuted block randomization schedule. This randomization list was generated by the study statistician using R with block size of 4 and stratified by gender and age (<55 and >=55 years old) and diabetes status (yes/no).

盲法：

Blinding：

NA

是否共享原始数据：

IPD sharing：

否

No

共享原始数据的方式（说明：请填入公开原始数据日期和方式，如采用网络平台，需填该网络平台名称和网址）：

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url)：

Data is available on request. The data will be shared upon reasonable request to the study leader

数据采集和管理（说明：数据采集和管理由两部分组成，一为病例记录表(Case Record Form, CRF)，二为电子采集和管理系统(Electronic Data Capture, EDC)，如ResMan即为一种基于互联网的EDC：

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture：

Study data were collected and managed using REDCap electronic data capture tools hosted at Vinmec International General Hospital JSC (1,2). REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed to support data capture for research studies, providing 1) an intuitive interface for validated data capture; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for data integration and interoperability with external sources. 1) PA Harris, R Taylor, R Thielke, J Payne, N Gonzalez, JG. Conde, Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform. 2009 Apr;42(2):377-81. 2) PA Harris, R Taylor, BL Minor, V Elliott, M Fernandez, L O’Neal, L McLeod, G Delacqua, F Delacqua, J Kirby, SN Duda, REDCap Consortium, The REDCap consortium: Building an international community of software partners, J Biomed Inform. 2019 May 9 [doi: 10.1016/j.jbi.2019.103208]

数据管理委员会：

Data Managemen Committee：

有

Yes

研究计划书或研究结果报告发表信息
（杂志名称、期、卷、页，时间；或网址）：

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

back
Platform information
About ITMCTR
About Us
Register Trials
Frequently Asked Questions
Ethical Review
The public service
Search Trials
Join Us
ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above